Product Information
GLIPIZIDE ER 5 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0737 per EA under NDC 60687088101. Its NADAC has been published 67 times since Jun 25, 2025.
FDA first approved this application on May 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
American Health PackagingNDC
60687088101
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLIPIZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206928FDA Approved
5/12/2017
TE Code
AB
On Market Since
4/4/2025
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE ER 5 MG TABLET has been published 67 times since Jun 25, 2025, and over the history we have for it it has declined 14.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0737 per EA |
|---|---|
| All-time high | $0.0858 (Jul 16, 2025) |
| All-time low | $0.0727 (Aug 19, 2026) |
| 52-week high | $0.0835 |
| 52-week low | $0.0727 |
| Median price | $0.0778 |
| Average price | $0.0787 |
| Largest weekly change | -3.4% (Nov 19, 2025) |
| Weeks tracked | 67 |
| Tracking since | Jun 25, 2025 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 54% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Health Packaging manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glipizide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonylurea class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLIPIZIDE ER 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE ER 5 MG TABLET, manufactured by American Health Packaging, is $0.0737 per EA (NDC 60687088101), effective Sep 30, 2026.
How has the price of GLIPIZIDE ER 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE ER 5 MG TABLET has declined 14.0%. It has been tracked across 67 weekly CMS publications since Jun 25, 2025.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE ER 5 MG TABLET?
Since Jun 25, 2025, the NADAC for GLIPIZIDE ER 5 MG TABLET has ranged from a low of $0.0727 (Aug 19, 2026) to a high of $0.0858 (Jul 16, 2025), with a median of $0.0778 per EA.
Are there cheaper alternatives to GLIPIZIDE ER 5 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLIPIZIDE 5 MG TABLET, is $0.0339 per EA — about 54% below GLIPIZIDE ER 5 MG TABLET.
Who manufactures GLIPIZIDE ER 5 MG TABLET?
GLIPIZIDE ER 5 MG TABLET (NDC 60687088101) is labeled by American Health Packaging, and CMS classifies it as a generic product.